Solutions
Company
Resources
Publications
Careers
Contact us
Skip to content
New and Noteworthy
Regulatory
Topics
Real-world evidence
Methodology
Health equity
Publications
Machine learning
Trial design
Label expansion
Post marketing requirements
Non-small cell lung cancer
Data science
HTA and market access
AP - Blythe Adamson, MPH, PhD
Treatment patterns
Content type
Video
Webinar
Article
Case study
Publication summary
Event recap
Podcast
Clear
Apply filter
Showing 9 of
0
results
Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in mNSCLC patients treated with chemotherapy
JCO Clinical Cancer Informatics
Real-world evidence
Non-small cell lung cancer
Regulatory
Assessing real-world data from electronic health records for health technology assessment: The SUITABILITY checklist: a good practices report of an ISPOR task force
Value in Health
Publication summary
Publications
Data science
Methodology
Regulatory
HTA and market access
AP - Blythe Adamson, MPH, PhD
FDA and Flatiron Health join forces to evaluate real-world outcomes in patients with organ impairment
Real-world evidence
Article
Regulatory
Navigating Medicare drug price negotiation in oncology: The need for real-world evidence
Real-world evidence
Article
Regulatory
Oncology case studies: How two life sciences companies applied real-world evidence to drive innovation
Real-world evidence
Video
Case study
Regulatory
Webinar
Flatiron partners with Friends of Cancer Research to advance the use of real-world response endpoints
Real-world evidence
Article
Methodology
Regulatory
The potential of real-world evidence: key learnings from ISPOR 2023
Real-world evidence
Event recap
Machine learning
Health equity
Regulatory
What have we learned: Adapting to RWE regulatory guidance and experience
Real-world evidence
Video
Regulatory
Webinar
Using a clinicogenomic real-world dataset to support a regulatory filing
Real-world evidence
Video
Case study
Regulatory
Webinar
View more